Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease

Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effect...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Yang, Bumhee, Jhun, Byung Woo, Moon, Seong Mi, Lee, Hyun, Park, Hye Yun, Jeon, Kyeongman, Kim, Dae Hun, Kim, Su-Young, Shin, Sung Jae, Daley, Charles L., Koh, Won-Jung
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2017
Teme:
Clinical Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444135/
https://ncbi.nlm.nih.gov/pubmed/28348153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02052-16
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki